Medical device developer Belluscura has signed its first US distribution agreement for the firm’s X-PLO2R portable oxygen concentrator portfolio.
Belluscura said the deal with the unnamed distributor, located on the East Coast of the United States, marked the first stage in establishing US-wide distribution coverage as part of its commercialisation strategy.
The AIM-listed firm added that the distributor immediately issued its first purchase order, with anticipated delivery of the first X-PLO2R portable oxygen concentrators expected in the third quarter of its current trading year.
Chief executive Robert Rauker said: “We are very pleased with the reception the X-PLO2R portable oxygen concentrator has received from distributors. We look forward to commercial launch in Q3 of 2021 and we anticipate signing a number of additional distribution agreements in the very near future.”
As of 1040 BST, Belluscura shares were up 13.13% at 56.0p.